LXLiwei Xing

Liwei Xing

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Liwei Xing has a total of 59 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Neuropeptides as neuroimmune modulators in chronic wound healing: mechanistic insights and emerging therapeutic strategies

    by Jiayi Wu, Manyan Zhao, Hongyan Wu, Xinran Duan, Daman Tian, Shuangfeng Xu, Ting Shi, Junfeng Lan, Zhifeng Wang, Jian Wang, et al.

    Chronic wounds, typified by diabetic foot ulcers, pressure ulcers, and venous leg ulcers, represent a major clinical challenge worldwide. Persistent inflammation associated with disrupted neuroimmune crosstalk is increasingly recognized as an important contributor to impaired chronic wound healing. Neuropeptides, including substance P, calcitonin gene-related peptide, neuropeptide Y, and vasoactive intestinal peptide, act as context-dependent neuroimmune mediators that regulate immune-cell states, inflammation resolution, angiogenesis, re-epithelialization, and extracellular-matrix remodeling through partly distinct mechanisms. This review systematically examines the molecular and cellular mechanisms through which these neuropeptides influence the chronic wound microenvironment, with particular attention to their dose-, phase-, receptor-, and cell-dependent effects. Emerging therapeutic strategies are also summarized, including conventional and stimuli-responsive hydrogels, nanoparticle–hydrogel composites, hydrogel microspheres, microneedles, electrospun scaffolds, cell-based approaches, extracellular-vesicle-based combination strategies, electrical stimulation, photobiomodulation, and anti-infective combination platforms. Most of the available evidence remains preclinical. Key translational challenges include peptide instability, receptor desensitization, wound heterogeneity, delivery-system manufacturing and standardization, and peptide-specific long-term safety. Collectively, current evidence supports neuropeptide signaling as a promising but context-dependent target for precision neuroimmune modulation in chronic wound healing.

  • Opportunities and challenges for the application of single-cell RNA sequencing and spatial transcriptomics in ischemic stroke

    by Zhifeng Wang, Zhihui Hao, Shuangfeng Xu, Hongyan Wu, Jiayi Wu, Manyan Zhao, RuiRui Wang, Liwei Xing, Jian Wang


  • Unveiling the pathogenesis and therapeutic strategies of Alzheimer’s disease through cuproptosis

    by Shuangfeng Xu, Jing Mu, Zhifeng Wang, Jiao Yang, Daman Tian, Ting Shi, Junfeng Lan, Pengfen He, Zhihui Hao, Youchuan Fu, et al.

    Alzheimer’s disease (AD), a leading cause of dementia, remains incurable, necessitating novel insights into its pathogenesis and therapeutic strategies. Recent studies highlight cuproptosis—a copper (Cu)-dependent mitochondrial cell death pathway—as a critical player in AD progression. Cuproptosis is triggered by Cu overload, which disrupts mitochondrial tricarboxylic acid cycle enzymes, resulting in toxic aggregation of lipoylated proteins and iron-sulfur cluster destabilization. This process exacerbates mitochondrial dysfunction, oxidative stress, and neuronal loss, synergizing with hallmark AD pathologies like Aβ deposition and Tau hyperphosphorylation. Unlike ferroptosis or apoptosis, cuproptosis uniquely involves mitochondrial protein lipoylation and Cu homeostasis imbalance. Therapeutic strategies targeting cuproptosis include Cu chelators, inhibitors of Cu transporters, antioxidants, and gene editing approaches to restore Cu homeostasis or mitigate protein aggregation. Immunotherapy and neuroprotective agents further show promise in alleviating cuproptosis-driven neuroinflammation. Despite preclinical advancements, challenges remain in balancing Cu’s essential roles with therapeutic interventions. This review underscores cuproptosis as a pivotal mechanism in AD and outlines emerging therapeutic avenues, emphasizing the ncessity for precision in targeting Cu dysregulation to halt neurodegeneration.


  • Open Access

    Heterogeneity of Microglia in Ischemic Stroke from the Perspective of Single-Cell RNA Sequencing: Subset Characteristics, Mechanisms and Therapeutic Potential

    by Daman Tian, Jiao Yang, Zhifeng Wang, Junfeng Lan, Ting Shi, Shuangfeng Xu, Manyan Zhao, Pengfen He, Jian Wang, Liwei Xing

    Ischemic stroke (IS), a predominant cerebrovascular disorder contributing to global disability and mortality, characterizes by a complex, multi-tiered cascade of pathological processes. As the primary innate immune cells within the central nervous system (CNS), microglia exhibit dual functional characteristics following ischemic injury, switching dynamically between pro-inflammatory detrimental phenotypes and anti-inflammatory reparative phenotypes in response to temporal progression, cellular phenotypic transformation, and changes in the local microenvironment. Consequently, therapeutic strategies targeting microglia have garnered considerable research interest, challenging the traditional neuron-centric therapeutic approaches. Microglia display a wide range of phenotypes, and the traditional M1/M2 classification is overly simplistic, failing to capture the full spectrum of their functional diversity. In contrast, single-cell RNA sequencing (scRNA-seq) technology has surpassed the limitations of bulk sequencing, providing a robust tool for elucidating microglial heterogeneity. Recent studies utilizing animal models of stroke have identified several subsets distinct from the conventional M1/M2-like subsets, including but no limited to ischemic stroke-associated microglia (ISAM), Prdx1 + SAM, Spp1 + microglia and SAM-foamy. The mechanisms underlying microglial heterogeneity encompass innate programming influenced by genetic background, dynamic remodeling of epigenetic modifications, metabolic reprogramming in response to extrinsic microenvironmental stress, and intercellular interaction networks. This review systematically examines, from the perspective of scRNA-seq, the biological functions of MG, the heterogeneity observed throughout their CNS life cycle development and regional homeostasis, the characteristics and regulatory mechanisms of heterogeneous microglial subpopulations following ischemic stroke, and potential therapeutic strategies and associated challenges. The aim is to provide a reference for the development of precise therapeutic strategies for IS.


  • Autonomic Nervous System Adaptation to Running in a Plateau Hypoxic Environment: Mechanisms and Prospects

    by Zhifeng Wang, Ting Shi, Shuangfeng Xu, Zhihui Hao, Jiao Yang, Huilan Zhao, Zongxu Liu, Jian Wang, Rong Zhao, Liwei Xing

  • Key copper homeostasis genes and inflammatory mechanisms in ischemic stroke: A bioinformatics and experimental study

    by Ting Shi, Zhifeng Wang, Jiao Yang, Pengfen He, Daman Tian, Junfeng Lan, Shuangfeng Xu, Aiming Yang, Liwei Xing, Yujiang Xi, et al.

    Ischemic stroke (IS) has high morbidity/mortality with limited treatments. This study screened core copper homeostasis-related genes in IS and validated their function as precise intervention targets. Human IS gene chip data were retrieved from GEO, and copper homeostasis genes from multiple databases. After data correction/normalization, IS differentially expressed genes (DEGs) were identified and intersected with copper genes. DAVID for GO/KEGG enrichment, STRING for PPI network, CytoHubba for key genes, and ROC curves for diagnostic value. MCAO rat models were established; after 14-day rearing, protein expression was validated via relevant assays. 1,425 IS DEGs and 2,610 copper genes intersected to 235 genes, enriched in inflammatory response, innate immunity, and TNF/NOD-like/Toll-like receptor pathways. Key genes HIF-1α, TNF, TLR4, IL-1β had IS diagnostic AUC 0.70–0.80. MCAO rats showed worse neurological deficits, larger infarcts, neuronal damage, brain copper accumulation, and upregulated key genes linked to neuroinflammation, BBB disruption, and neuronal injury. Bioinformatics and animal studies revealed copper homeostasis imbalance-related genes mediate inflammation, oxidative stress, and mitochondrial regulation, supporting the "copper accumulation–inflammation–oxidative stress" cascade. These genes may be novel IS targets. Further study on dynamic expression across ischemic time windows/brain regions and interactions with other cell death modes is needed. Graphical abstract This study used a system approach: bioinformatics screening → experimental validation → mechanism elucidation. Three cerebral ischemia datasets from GEO (GSE16561, GSE22255, GSE58294) underwent DEG analysis; Venn diagram identified core shared DEGs. GO/KEGG enrichment, STRING for PPI network, Cytoscape for hub genes, ROC curves for diagnostic potential. Rat MCAO model was established; validity verified via relevant staining; Cu2+ accumulation detected; molecular expression validated by assays.


  • Open Access

    Application of Acupuncture in Diabetic Vascular Complications: Efficacy and Potential Mechanisms

    by Zhifeng Wang, Ying Chen, Ting Shi, Jiao Yang, Daman Tian, Hongyan Wu, Rong Zhao, Ruirui Wang, Liwei Xing

    Diabetes and its complications are a major global public health issue. Conventional Western medicine has limitations in efficacy and safety in managing complications, while acupuncture, with multitarget regulation and low side effects, serves as an important supplementary therapy. This review discusses how acupuncture relieves macrovascular complications, such as angina and cerebral reperfusion, by inhibiting NF‐ κ B, improving vascular endothelial function, and regulating autonomic nerves. In addition, acupuncture delays microvascular complications, such as retinopathy and proteinuria via vasodilation, anti‐inflammatory effects, antioxidative effects, and neurotrophic promotion. Acupuncture also benefits other complications by enhancing microcirculation and neuroendocrine function. The mechanisms of acupuncture involve regulating the metabolic‐inflammatory‐neurovascular network, activating pathways (such as GLP‐1 and SDF‐1), and repairing cellular structures. Modern technologies—including artificial intelligence (AI) for individualized acupoint selection, functional magnetic resonance imaging (fMRI) for central regulation visualization, and biomaterial combination for diabetic foot repair—enhance the precision of acupuncture. However, clinical translation of acupuncture faces the following challenges: fragmented mechanisms; insufficient clinical evidence, including small samples, short follow‐ups, and a lack of long‐term safety data when used with new hypoglycemics; and technical nonstandardization, such as inconsistent acupoint selection, nonuniform operation parameters, and poor adaptability of AI to traditional Chinese medicine syndrome differentiation. Future research should deepen the exploration of the neuroendocrine–immune network via interdisciplinary integration, conducting large‐sample long‐term trials, establishing standardized protocols, and validating AI/fMRI‐assisted precision acupoint selection to accelerate the transition of acupuncture from adjuvant to precision therapy to improve patients’ quality of life.


  • Retracted
    Open Access

    [Retracted] Preventive Electroacupuncture Alleviates Oxidative Stress and Inflammation via Keap1/Nrf2/HO‐1 Pathway in Rats with Cyclophosphamide‐Induced Premature Ovarian Insufficiency

    by Yang Chen, Rui Zhao, Xiang Li, Yun-Peng Luan, Li-Wei Xing, Xiao-Juan Zhang, Jing Wang, Xiao-Yan Xia, Rong Zhao

    Electroacupuncture (EA) is a popular therapeutic therapy for premature ovarian insufficiency (POI). However, little has been known about the underlying processes of EA therapy. To investigate the benefit of EA and reveal the mechanism, thirty SD female rats were allocated into the control, model, sham, EA, and GnRHa groups at random. Vaginal smears were used to monitor the rats’ estrous cycle. Serum liver and renal function (ALT, AST, BUN, and Cr), sex hormone (FSH, E2, and AMH), oxidative stress markers (SOD, GSH, and MDA), and inflammatory cytokine (IL6, IL1β, and TNFα) levels were measured by enzyme‐linked immunosorbent assay (ELISA). Their ovary morphology was observed by hematoxylin‐eosin staining. Transmission electron microscope was used to remark the ultrastructure of the granulocytes. Protein and gene expressions of Keap1/Nrf2/HO‐1 pathway were detected by western blot and RT‐PCR. Compared with the model group, in the EA group, the levels of serum sex hormones recovered to normal levels. Moreover, it reduced oxidative stress in rats, as demonstrated by increased SOD and GSH levels and decreased MDA levels. Meanwhile, Keap1 mRNA and protein expression dropped considerably in the EA group, while the mRNA and protein expressions of Nrf2 and HO‐1 increased. We found that preventive EA might rescue rats with CTX‐induced ovarian dysfunction. The anti‐inflammatory and antioxidative stress properties of EA, which elevated the Keap1/Nrf2/HO‐1 signaling pathway, might be the underlying mechanism. Furthermore, as compared to GnRHa, electroacupuncture did not raise the burden of the liver (ALT and AST) or the kidney (BUN and Cr). Electroacupuncture has a meaningful impact and a sufficient level of safety, making it useful for therapeutic setting in POI.


  • Open Access

    Acupuncture Improves Endometrial Angiogenesis by Activating PI3K/AKT Pathway in a Rat Model with PCOS

    by Liwei Xing, Yang Chen, Zhe He, Ming He, Yuhuan Sun, Jinlong Xu, Jian Wang, Haina Zhuang, Zeqin Ren, Ying Chen, et al.

    Background. Acupuncture, a treatment derived from traditional Chinese medicine, can effectively relieve the symptoms and improve pregnancy outcome in patients with polycystic ovary syndrome (PCOS); however, its mechanism remains unclear. This study aimed at investigating whether acupuncture could improve endometrial angiogenesis and thus endometrial receptivity via activating PI3K/AKT pathway in PCOS rats. Methods. We established a rat model with PCOS, which was induced by DHEA. Acupuncture was performed every other day for 15 days, and the PI3K inhibitor (LY294002) was intraperitoneal injected 30 mins before acupuncture treatment. Females rats were mated with male SPF SD rats in a ratio of 2:1 after treatment and sacrificed on the 5th day when the vaginal plug was identified. The number of implantation sites was observed, followed by ovarian and endometrial morphology detected with hematoxylin-eosin staining and a scanning electron microscope, estrous cycle detected with vaginal smear analysis, and sex hormones and angiogenesis-related PI3K/AKT gene/protein expression detected with enzyme-linked immunosorbent assay, western blotting, immune histochemistry, and quantitative real-time PCR. Results. Acupuncture notably improved implantation sites number, endometrial receptivity factors including endometrial morphology, pinopodes, HOX-10, and LIF protein expression, as well as angiogenesis and PI3K/AKT pathway factors such as VEGF, VEGFR2, Ang-1, PI3K, AKT, and P-AKT gene/protein expression and the level of eNOS and NO in the endometrium of rats with PCOS; PCOS-like symptoms were alleviated as well. The efficacy of acupuncture on a rat model with PCOS was counteracted by the combination with the PI3K inhibitor. Conclusion. Acupuncture improves endometrial angiogenesis by activating the PI3K/AKT pathway, thus promoting endometrial receptivity and the number of implantation sites in rats with PCOS.


  • Open Access

    Effect of Acupoint Embedding on Serum Leptin and Hypothalamus Leptin Receptor Expression in Rats with Simple Obesity

    by Qiming Yang, Liwei Xing, Qinzuo Dong, Hongxi Chen, Chunlin Xia, Xianwu Yue, Yuanfeng Wang, Li Li, Yingjing Luo, Mingxing Lai, et al.

    Background. Acupoint embedding treatment on obesity has been applied in clinical practice for many years and has achieved obvious efficacy. However, animal experimental studies on acupoint embedding are relatively few, and its mechanism remains unclear. Methods. We established a simple obese rat model using a high-fat diet for 8 weeks. Acupoint embedding therapy was performed once a week for 4 weeks. After the treatment, serum leptin, triglyceride (TG), cholesterol (TC), low-density lipoprotein (LDL), and high-density lipoprotein (HDL) levels were detected by radioimmunoassay, HE staining was used for fat morphology analysis, and immunohistochemical method was used to detect the expression of leptin receptor in hypothalamus. Results. Compared with model group, acupoint embedding treatment can reduce body weight and Lee's index, reduce serum leptin, TG, TC, and LDL level, increase HDL level, change the morphology and number of adipocytes, and increase the expression of leptin receptor in hypothalamus. Conclusion. Acupoint embedding therapy can reduce the level of leptin in blood, increase the number of leptin receptors in hypothalamus, enhance the biological effect of leptin, alleviate the leptin resistance in obese body, change the shape of fat, and regulate the level of blood lipid, so as to achieve the goal of weight loss.